Could Malassezia yeasts be implicated in skin carcinogenesis through the production of aryl-hydrocarbon receptor ligands?

Medical Hypotheses

Volumn 77, Issue 1, 2011, Pages 47-51

  Gaitanis, G ^a   Velegraki, A ^b   Magiatis, P ^c   Pappas, P ^a   Bassukas, I D ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR;

APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; CELL CYCLE PROGRESSION; HUMAN; IMMUNOLOGICAL TOLERANCE; MALASSEZIA; NONHUMAN; RADIATION CARCINOGENESIS; SKIN CARCINOGENESIS; TUMOR CELL; TUMOR PROMOTION; ULTRAVIOLET RADIATION; VITAMIN D METABOLISM;

HUMANS; LIGANDS; MALASSEZIA; RECEPTORS, ARYL HYDROCARBON; SKIN NEOPLASMS;

ANIMALIA; MALASSEZIA; MALASSEZIA FURFUR;

EID: 79958054233     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.03.020     Document Type: Article

References (72)

1. Ashbee H.R. Update on the genus Malassezia. Med Mycol 2007, 45:287-303.
2. Cabañes F.J., Theelen B., Castellá G., Boekhout T. Two new lipid-dependent Malassezia species from domestic animals. FEMS Yeast Res 2007, 7:1064-1076.
3. Tajima M., Sugita T., Nishikawa A., Tsuboi R. Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. J Invest Dermatol 2008, 128:345-351.
4. Gaitanis G., Velegraki A., Alexopoulos E.C., Chasapi V., Tsigonia A., Katsambas A. Distribution of Malassezia species in pityriasis versicolor and seborrhoeic dermatitis in Greece. Typing of the major pityriasis versicolor isolate M. globosa. Br J Dermatol 2006, 154:854-859.
5. Mayser P., Gaitanis G. Physiology and biochemistry. Malassezia and the skin 2010, 121-138. Springer, Heidelberg, Germany. T. Boekhout, E. Gueho-Kellermann, P. Mayer, A. Velegraki (Eds.).
6. Gaitanis G., Magiatis P., Stathopoulou K., et al. AhR ligands, malassezin, and indolo[3,2-b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis. J Invest Dermatol 2008, 128(7):1620-1625.
7. Giakoumaki D., Stathopoulou K., Melliou E., et al. Identification of Indirubin as a metabolite of Malassezia furfur strains isolated from diseased skin. Planta Medica 2008, 74(9):1081.
8. Gaitanis G., Pappas P., Magiatis P., et al. The seborrheic dermatitis associated Malassezia índoles induce the aryl-hydrocarbon receptor (AhR) dependent genes in HaCaT cells. J Invest Dermatol 2009, 129:S103.
9. Gaitanis G., Galanou M., Magiatis P., et al. The Malassezia metabolites indirubin and malassezin are potent activators of the aryl hydrocarbon receptor in HaCaT cells. J Invest Dermatol 2010, 130:S91.
10. Knockaert M., Blondel M., Bach S., et al. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene 2004, 23(25):4400-4412.
11. Crespo-Erchiga V., Hay R.J. Pityriasis versicolor and other Malassezia skin diseases. Malassezia and the skin 2010, 175-200. Springer, Heidelberg, Germany. T. Boekhout, E. Gueho-Kellermann, P. Mayer, A. Velegraki (Eds.).
12. Gaitanis G., Mayser P., Scheynius A., Crameri R. Malassezia yeasts in seborrheic and atopic eczema. Malassezia and the skin 2010, 201-228. Springer, Heidelberg, Germany. T. Boekhout, E. Gueho-Kellermann, P. Mayer, A. Velegraki (Eds.).
13. Darabi K., Hostetler S.G., Bechtel M.A., Zirwas M. The role of Malassezia in atopic dermatitis affecting the head and neck of adults. J Am Acad Dermatol 2009, 60(1):125-136.
14. Fry L., Baker B.S. Triggering psoriasis: the role of infections and medications. Clin Dermatol 2007, 25(6):606-615.
15. Krämer H.J., Kessler D., Hipler U.C., et al. Pityriarubins, novel highly selective inhibitors of respiratory burst from cultures of the yeast Malassezia furfur: comparison with the bisindolylmaleimide arcyriarubin A. Chembiochem 2005, 6(12):2290-2297.
16. Gupta A.K., Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol 2004, 18(1):13-26.
17. Krämer H.J., Podobinska M., Bartsch A., et al. Malassezin, a novel agonist of the aryl hydrocarbon receptor from the yeast Malassezia furfur, induces apoptosis in primary human melanocytes. Chembiochem 2005, 6(5):860-865.
18. Lally A., Casabonne D., Newton R., Wojnarowska F. Seborrhoeic dermatitis among Oxford renal transplant recipients. J Eur Acad Dermatol Venereol 2010, 24(5):561-564.
19. Prohic A. Distribution of Malassezia species in seborrhoeic dermatitis: correlation with patients' cellular immune status. Mycoses 2010, 53(4):344-349.
20. Heckmann M., Zogelmeier F., Konz B. Frequency of facial basal cell carcinoma does not correlate with site-specific UV exposure. Arch Dermatol 2002, 138:1494-1497.
21. MacKie R.M., Quinn A.G. Non-melanoma skin cancer and other epidermal skin tumors. Rook's textbook of dermatology 2004, 36-1-36-50. Blackwell Science Ltd., Oxford. 7th ed. T. Burns, S. Breathnach, N. Cox, C. Griffiths (Eds.).
22. Hutchin M., Kariapper M., Grachtchouk M., et al. Sustained hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Develop 2005, 19:214-223.
23. Epstein E.H. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008, 8(10):743-754.
24. Kim J., Modlin R., Moy R., et al. IL-10 Production in cutaneous basal and squamous cell carcinoma. A mechanism for evading the local and T-cell immune response. J Immunol 1995, 155:2240-2247.
25. Kaporis H.G., Guttman-Yassky E., Lowes M.A., et al. Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment. J Invest Dermatol 2007, 127(10):2391-2398.
26. Zitvogel L., Tesniere A., Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006, 6:715-727.
27. Afaq F., Zaid M.A., Pelle E., et al. Aryl hydrocarbon receptor is an ozone sensor in human skin. J Invest Dermatol 2009, 129(10):2396-2403.
28. Bock K.W., Köhle C. The mammalian aryl hydrocarbon (Ah) receptor: from mediator of dioxin toxicity toward physiological functions in skin and liver. Biol Chem 2009, 390(12):1225-1235.
29. Fritsche E., Schäfer C., Calles C., et al. Lightening up the UV response by identification of the aryl hydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc Natl Acad Sci USA 2007, 104(21):8851-8856.
30. Agostinis P., Garmyn M., Van Laethem A. The aryl hydrocarbon receptor: an illuminating effector of the UVB response. Sci STKE 2007, (403):pe49.
31. Tijet N., Boutros P.C., Moffat I.D., Okey A.B., Tuomisto J., Pohjanvirta R. Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol 2006, 69(1):140-153.
32. Marshall N.B., Kerkvliet N.I. Dioxin and immune regulation. Ann NY Acad Sci 2010, 1183:25-37.
33. Panteleyev A.A., Bickers D.R. Dioxin-induced chloracne - reconstructing the cellular and molecular mechanisms of a classic environmental disease. Exp Dermatol 2006, 15(9):705-730.
34. Ray S.S., Swanson H.I. Alteration of keratinocyte differentiation and senescence by the tumor promoter dioxin. Toxicol Appl Pharmacol 2003, 192(2):131-145.
35. Loertscher J.A., Lin T.M., Peterson R.E., Allen-Hoffmann B.L. In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin causes accelerated terminal differentiation in fetal mouse skin. Toxicol Sci 2002, 68(2):465-472.
36. Esser C., Rannug A., Stockinger B. The aryl hydrocarbon receptor in immunity. Trends Immunol 2009, 30(9):447-454.
37. Ray S., Swanson H.I. Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event?. Biochem Pharmacol 2009, 77(4):681-688.
38. Levine-Fridman A., Chen L., Elferink C.J. Cytochrome P4501A1 promotes G1 phase cell cycle progression by controlling aryl hydrocarbon receptor activity. Mol Pharmacol 2004, 65(2):461-469.
39. Wanner R., Panteleyev A., Henz B.M., Rosenbach T. Retinoic acid affects the expression rate of the differentiation-related genes aryl hydrocarbon receptor, ARNT and keratin 4 in proliferative keratinocytes only. Biochim Biophys Acta 1996, 1317(2):105-111.
40. Ikuta T., Namiki T., Fujii-Kuriyama Y., Kawajiri K. AhR protein trafficking and function in the skin. Bioch Pharmacol 2009, 77:588-596.
41. Lear J.T., Smith A.G., Strange R.C., Fryer A.A. Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy. Br J Dermatol 2000, 142(1):8-15.
42. Ramachandran S., Fryer A.A., Smith A., et al. Cutaneous basal cell carcinomas: distinct host factors are associated with the development of tumors on the trunk and on the head and neck. Cancer 2001, 92(2):354-358.
43. Ferreira J., Silva J.M., Freire R., et al. Skin cancers and precancerous lesions in Parkinson's disease patients. Mov Disord 2007, 22:1471-1475.
44. Bond R., Guillot J., Cabañes J. Malassezia yeasts in animal disease. Malassezia and the skin 2010, 271-300. Springer, Heidelberg, Germany. T. Boekhout, E. Gueho-Kellermann, P. Mayer, A. Velegraki (Eds.).
45. The merck veterinary manual. Basal cell tumors and basal cell carcinomas. Available from: http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/72203.htm.
46. Rothwell T.L., Howlett C.R., Middleton D.J., Griffiths D.A., Duff B.C. Skin neoplasms in dogs in Sydney. Austr Vet J 1987, 64:161-164.
47. von Bomhard W., Goldschmidt M.H., Shofer F.S., Perl L., Rosenthal K.L., Mauldin E.A. Cutaneous neoplasms in pet rabbits: a retrospective study. Vet Pathol 2007, 44(5):579-588.
48. Schrenk D., Schmitz H.J., Bohnenberger S., Wagner B., Wörner W. Tumor promoters as inhibitors of apoptosis in rat hepatocytes. Toxicol Lett 2004, 149(1-3):43-50.
49. IARC working group on the evaluation of carcinogenic risks to humans: polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. IARC Monogr Eval Carcinog Risks Hum 1997;69:1-631.
50. Roelofzen J.H., Aben K.K., Oldenhof U.T., et al. No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema. J Invest Dermatol 2010, 130(4):953-961.
51. Faergemann J., Bergbrant I.M., Dohsé M., Scott A., Westgate G. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol 2001, 144(3):549-556.
52. Hauben E., Gregori S., Draghici E., et al. Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 2008, 112(4):1214-1222.
53. Elferink C.J. Aryl hydrocarbon receptor-mediated cell cycle control. Prog Cell Cycle Res 2003, 5:261-267.
54. Barhoover M.A., Hall J.M., Greenlee W.F., Thomas R.S. Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4. Mol Pharmacol 2010, 77(2):195-201.
55. Marlowe J.L., Fan Y., Chang X., et al. The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Mol Biol Cell 2008, 19(8):3263-3271.
56. Morita A., Torii K., Maeda A., Yamaguchi Y. Molecular basis of tobacco smoke-induced premature skin aging. J Investig Dermatol Symp Proc 2009, 14(1):53-55.
57. Murphy K.A., Villano C.M., Dorn R., White L.A. Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metalloproteinase-1 expression in keratinocytes. J Biol Chem 2004, 279(24):25284-25293.
58. Schwarz M., Buchman A., Stinchcombe S., Kalkuhl A., Bock K.-W. Ah receptor ligands and tumor promotion: survival of neoplastic cells. Toxicol Lett 2000, 112-113:69-77.
59. Dragan Y.P., Schrenk D. Animal studies addressing the carcinogenicity of TCDD (or related compounds) with an emphasis on tumour promotion. Food Addit Contam 2000, 17:289-302.
60. Matsunawa M., Amano Y., Endo K., et al. The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages. Toxicol Sci 2009 May, 109(1):50-58.
61. Meijer L., Skaltsounis A.L., Magiatis P., et al. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol 2003, 10(12):1255-1266.
62. Takenaka K., Kise Y., Miki H. GSK3β positively regulates Hedgehog signaling through Sufu in mammalian cells. Bioch Biophys Res Comm 2007, 353:501-508.
63. Gaitanis G., Chasapi V., Velegraki A. Novel application of the Masson-Fontana stain for demonstrating Malassezia species melanin-like pigment production in vitro and in clinical specimens. J Clin Microbiol 2005, 43(8):4147-4151.
64. Larangeira de Almeida H., Mayser P. Absence of sunburn in lesions of pityriasis versicolor alba. Mycoses 2006, 49(6):516.
65. Evan Gi, Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411(6853):342-348.
66. Jux B., Kadow S., Esser C. Langerhans cell maturation and contact hypersensitivity are impaired in aryl hydrocarbon receptor-null mice. J Immunol 2009, 182(11):6709-6717.
67. Gaitanis G., Bassukas I.D., Velegraki A. The range of molecular methods for typing Malassezia. Curr Opin Infect Dis 2009, 22(2):119-125.
68. Gaitanis G., Velegraki A., Alexopoulos E.C., et al. Malassezia furfur fingerprints as possible markers for human phylogeography. ISME J 2009, 3(4):498-502.
69. Pfister H. Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003, (31):52-56.
70. Houben R., Schrama D., Becker J.C. Molecular pathogenesis of Merkel cell carcinoma. Exp Dermatol 2009, 18(3):193-198.
71. Malfertheiner P., Bornschein J., Selgrad M. Role of Helicobacter pylori infection in gastric cancer pathogenesis: a chance for prevention. J Dig Dis 2010, 11(1):2-11.
72. Malfertheiner P., Bornschein J., Selgrad M., Yosry E. Schistosomiasis and neoplasia. Infection and inflammation: impacts on oncogenesis 2006, 81-100. Karger, Basel, Switzerland. T. Dittmar, K.S. Zaenker, A. Schmidt (Eds.).